Jesus Gonzalo Asensio

Title: Innovations in Tuberculosis Vaccination by Jesus Gonzalo Asensio

Introduction

Jesus Gonzalo Asensio is a notable inventor based in Zaragoza, Spain. He has made significant contributions to the field of medical research, particularly in the development of vaccines for tuberculosis. With a total of 2 patents to his name, Asensio's work is paving the way for advancements in immunization against this serious disease.

Latest Patents

Asensio's latest patents focus on an innovative tuberculosis vaccine. The first patent describes an isolated microorganism belonging to the genus, characterized by the inactivation of the gene Rv0757, which confers a PhoP− phenotype. This invention also includes the inactivation of a second gene that prevents the production of DIM, leading to a DIM− phenotype. The patent outlines the use of this microorganism for producing a vaccine aimed at immunizing against or preventing tuberculosis. The second patent similarly details an isolated microorganism with one or both of the inactivated genes, along with methods for creating the microorganism, related pharmaceutical formulations, and vaccines. These formulations may also serve as vectors or adjuvants in treatment.

Career Highlights

Asensio is affiliated with the Universidad de Zaragoza, where he conducts his research and development work. His contributions to the field of vaccine development are recognized and valued within the academic and medical communities.

Collaborations

Asensio has collaborated with esteemed colleagues, including Carlos Martin Montanes and Brigitte Gicquel. Their joint efforts have further enhanced the research and development of innovative solutions in the fight against tuberculosis.

Conclusion

Jesus Gonzalo Asensio's work in developing tuberculosis vaccines represents a significant advancement in medical science. His innovative approaches and collaborations are crucial in the ongoing battle against infectious diseases.